https://www.selleckchem.com/
Nearly all providers (93%) reported they would consider using a short, validated screening tool for ND and MH concerns if such tools were available. A minority of pediatric endocrinologists currently perform ND or MH screening for patients with TS, however, many would be interested in implementing a brief screening tool into their clinical practice. Given almost all girls with a TS diagnosis receive care from pediatric endocrinologists at least annually, this may be an effective method to increase the proportion of girls with TS who receive recommended